Publication - Advice and guidance

Coronavirus (COVID-19) AstraZeneca vaccine (ChAdOx1-S [Recombinant]): national protocol v2.4

This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme. This protocol only allows supply and administration during or in anticipation of the COVID-19 pandemic.

Coronavirus (COVID-19) AstraZeneca vaccine (ChAdOx1-S [Recombinant]): national protocol v2.4
3. Change history

3. Change history

Version number

Change details

Date

V01.00

New protocol for AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) vaccine.

21 January 2021

V02.00

Updated protocol to reflect Armed Services staff roles

02 February 2021

V02.1

Clinical annex updated

22 February 2021

V02.2

Clinical annex updated

20 April 2021

V02.3

Clinical annex updated

10 May 2021

V02.4

Clinical annex updated

24 May 2021


Contact

Email: vaccineoperationaloversight@gov.scot